Wilkinson S P, Wheeler P G, Bernardi M, Smith I K, Williams R
Postgrad Med J. 1979 Dec;55(654):862-7. doi: 10.1136/pgmj.55.650.862.
In 4 patients with cirrhosis and ascites, diuretic therapy resulted in an impairment of renal function that was associated with a rise in plasma renin activity (PRA). In 3, this occurred in the absence of volume depletion. When diuretics were discontinued, renal function returned to normal. beta-adrenergic blocking drugs were then given to suppress renin secretion and diuretics restarted. On this occasion, impairment of renal function did not occur. In 2 further patients, administration of beta-adrenergic blockers during a period of diuretic-induced renal impairment resulted in an improvement in renal function. Although these findings may indicate that diuretic-induced renal impairment in cirrhosis is at least partly due to activation of the renin-angiotensin system, in another group of patients a diuretic-induced rise in PRA was not associated with a deterioration in renal function.
在4例肝硬化腹水患者中,利尿治疗导致肾功能损害,且与血浆肾素活性(PRA)升高有关。在3例患者中,这种情况发生在不存在血容量减少的情况下。停用利尿剂后,肾功能恢复正常。随后给予β-肾上腺素能阻滞剂以抑制肾素分泌,并重新开始使用利尿剂。此时,未出现肾功能损害。在另外2例患者中,在利尿诱导的肾功能损害期间给予β-肾上腺素能阻滞剂导致肾功能改善。尽管这些发现可能表明肝硬化中利尿诱导的肾功能损害至少部分归因于肾素-血管紧张素系统的激活,但在另一组患者中,利尿诱导的PRA升高与肾功能恶化无关。